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Addictive drugs can activate systems involved in normal reward-related learning, creating
long-lasting memories of the drug’s reinforcing effects and the environmental cues
surrounding the experience. These memories significantly contribute to the maintenance
of compulsive drug use as well as cue-induced relapse which can occur even after
long periods of abstinence. Synaptic plasticity is thought to be a prominent molecular
mechanism underlying drug-induced learning and memories. Ethanol and nicotine are
both widely abused drugs that share a common molecular target in the brain, the
neuronal nicotinic acetylcholine receptors (nAChRs). The nAChRs are ligand-gated ion
channels that are vastly distributed throughout the brain and play a key role in synaptic
neurotransmission. In this review, we will delineate the role of nAChRs in the development
of ethanol and nicotine addiction. We will characterize both ethanol and nicotine’s effects
on nAChR-mediated synaptic transmission and plasticity in several key brain areas that
are important for addiction. Finally, we will discuss some of the behavioral outcomes of
drug-induced synaptic plasticity in animal models. An understanding of the molecular and
cellular changes that occur following administration of ethanol and nicotine will lead to
better therapeutic strategies.
Keywords: addiction, behavioral sensitization, cholinergic, ethanol, neuroplasticity, nicotine, nicotinic
acetylcholine receptors, synaptic transmission
INTRODUCTION
For the past several decades researchers have put forth concerted
efforts to investigate the effects of drugs of abuse on brain func-
tion with the ultimate goal of developing medications useful in
terminating drug use and preventing relapse. The progression
from initial drug use to drug dependence involves complex, mul-
tifaceted neural adaptations that encompass molecular changes at
the cellular level within several different brain circuits. From stud-
ies involving human subjects and animal models, drugs of abuse
are known to act on the cortico-limbic network (see Figure 1)
that governs reward (mesolimbic dopaminergic pathway), learn-
ing and memory (hippocampus), emotion (amygdala), and exec-
utive functions (prefrontal cortex). Our understanding, at this
point, remains limited regarding how drug-related experiences
are encoded in the brain and their relationship to synaptic plas-
ticity and the development of addictions.
It is now generally accepted that addiction is a type of learning,
i.e., learned associations between the rewarding effects of drugs
and environmental cues that predict drug availability, which sig-
nificantly contributes to compulsive drug use and the propensity
to relapse even after long periods of abstinence. As subjects
make the transition from initiation to habitual drug use, neuro-
adaptations in areas such as the hippocampus and amygdala
are thought to underlie drug-associated learning and memories.
A single episode of drug use itself can influence synaptic transmis-
sion and repeated or prolonged drug use can cause long-lasting
alterations in synaptic strengths—defined as synaptic plasticity,
reflected through molecular changes as well as persistent modifi-
cation of neurotransmitter release. These drug-induced changes
in the brain are a critical component in the development of
dependence and are thought to drive compulsive intake and
relapse. There are many factors that play into addictive processes
and understanding the neurobiological underpinnings of these
events will enlighten possible therapeutic targets.
The most well-known form of synaptic plasticity, NMDAR-
dependent, was first discovered in 1973 in the hippocampi of
anesthetized rats (Bliss and Lomo, 1973) and has since been
extensively characterized from electrophysiological recordings of
in vitro hippocampal slice preparations. Long-term potentiation
(LTP) is defined as an increase in the post-synaptic response
resulting from a cascade of events which is initiated by an influx of
Ca2+ ions through voltage-gated pre-synaptic ion channels. The
NMDAR-dependent form of LTP requires postsynaptic depolar-
ization during NMDAR activation, which will allow for an influx
of Ca2+ ions through the channel within the dendritic spine. This
increase of Ca2+ will commence a series of intracellular signal-
ing, activating a number of protein kinases and consequently lead
to the insertion of AMPA receptors into the plasma membrane.
In contrast, long term depression (LTD) is attributed to a weak
activation of NMDARs, minimal Ca2+ influx, and a reduction
in post-synaptic AMPA surface receptor density via dynamin-
and clathrin-dependent endocytosis (Malenka and Bear, 2004).
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FIGURE 1 | Neuronal nicotinic acetylcholine receptors (nAChRs) are
widely distributed in different brain regions that include the ventral
tegmental area (VTA), nucleus accumbens (NAc), hippocampus,
prefrontal cortex (PFC), and amygdala. Activation of nAChRs in these
brain areas significantly contribute to the rewarding effects of ethanol and
nicotine and play a role in modulating synaptic plasticity. GABAergic (red),
glutamatergic (green), and dopaminergic (blue) connections between these
structures constitute a major neural circuitry underlying addictive disorders.
Much of the NMDAR-dependent plasticity has focused on mech-
anisms responsible for the initial increase in synaptic strength,
however the long-lasting biological effects likely require new pro-
tein synthesis and gene transcription (Lynch, 2004). There are
quantifiable alterations in the morphology of dendrites and den-
dritic spines that accompany LTP (Andersen and Soleng, 1998;
Yuste and Bonhoeffer, 2001; Matsuzaki et al., 2004) and together
these long-lasting changes have been implicated as an essen-
tial mechanism and molecular basis for learning and memory.
Additionally, there are other modulators of plasticity, such as
metabotropic glutamate receptors and endocannabinoids, that
have been discovered and reviewed extensively elsewhere [see
review, Kauer and Malenka (2007)].
Alcohol and tobacco addiction are among the highest causes
of preventable death worldwide (Mokdad et al., 2004) and the
comorbidity of these two substance abuse disorders is striking
(DiFranza and Guerrera, 1990; Batel et al., 1995; Falk et al.,
2006). While the easy availability and low social stigma of alcohol
and cigarettes provides an explanation of their high prevalence
of dual dependence, strong neurobiological evidence suggests a
common link between these two substances (de Fiebre et al.,
1990; Smith et al., 1999; Gould et al., 2001; Marubio et al.,
2003; Tizabi et al., 2007). Neuronal nicotinic acetylcholine recep-
tors (nAChRs) are widely expressed throughout the brain (Gotti
et al., 2007) and are suggested to be the common biological tar-
get of nicotine and ethanol (Tapper et al., 2004; Funk et al.,
2006; Steensland et al., 2007; Bito-Onon et al., 2011). nAChRs
are pentameric ligand-gated ion channels, consisting of various
heteromeric or homomeric combinations of α (α2–α10) and β
(β2–β4) subunits (Albuquerque et al., 2009; Gotti et al., 2009).
Most neuronal nAChRs are heteromeric receptors with just two
binding sites, but some subunits, such as the α7, form functional
homomeric receptors with five binding sites (Changeux, 2009;
Gotti et al., 2009). The most abundant of nAChR subtypes in
the brain are the α4β2∗ (∗indicates the possibility of other sub-
units) followed by the α7; correspondingly, the mRNA of these
subtypes are found throughout the entire brain. The vast regional
distribution and location of nAChRs are thoroughly reported in
the following reviews (Gotti and Clementi, 2004; Gotti et al.,
2007).
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Binding of endogenous acetylcholine (ACh) or nicotine
induces a conformational change of the receptor allowing for an
influx of cations (Ca2+, Na+, or K+ depending on nAChR sub-
type) through the central channel for a few milliseconds, followed
by a non-conducting closed receptor state (Giniatullin et al.,
2005). In contrast, ethanol is not a direct agonist at nAChRs but
can potentiate the response of these receptors to Ach (Aistrup
et al., 1999; Cardoso et al., 1999; Zuo et al., 2002). The pharmaco-
logical properties of the nAChRs to agonists such as ACh, nicotine
or ethanol is highly dependent on its subunit composition and
location of the receptor (Yu et al., 1996; Pidoplichko et al., 1997;
Cardoso et al., 1999; Wooltorton et al., 2003).
Nicotinic receptors are localized both pre- and post-
synaptically where agonist-induced cation influx results in mem-
brane depolarization and/or CA2+-dependent signaling cascades,
thereby regulating neuronal excitability and neurotransmitter
release (Albuquerque et al., 1995). nAChRs play a significant
role in modulating glutamatergic, GABAergic, and dopaminergic
neurotransmission in the mesolimbic pathway (Blomqvist et al.,
1992; Caille et al., 2009; Mao et al., 2011), thus contributing to
the rewarding effects of drugs of abuse and synaptic plasticity in
this system as well as in other brain regions such as the hippocam-
pus and amygdala (Ericson et al., 2009; Hendrickson et al., 2010;
Reperant et al., 2010). Moreover upon exposure to nicotine and
ethanol, nicotinic receptors can undergo changes in expression
(stoichiometries or receptor number) and function which may
underlie aspects of physical dependence and withdrawal symp-
toms (Nashmi et al., 2007). Since the majority of alcoholics are
also smokers, determining the coincident molecular underpin-
nings in the development of their dependence may be useful in
treating these addictions.
This review will attempt to consolidate the available informa-
tion regarding nicotinic receptor-mediated synaptic plasticity and
integrate these enduring neural adaptations with current mod-
els of addictive disorders. We will look at a myriad of addictive
processes, the underlying neural circuits and how these path-
ways converge for addictive behaviors to emerge. The complexity
of addictive disorders suggests there are a considerable num-
ber of possible targets for intervention that could potentially
reverse drug-induced neural adaptations. We will aim to focus
this paper towards nicotinic receptor-mediated neuroplasticity,
with an emphasis on nicotine and ethanol.
NICOTINE AND ETHANOL: nAChR-MEDIATED
NEUROTRANSMISSION AND PLASTICITY
In addition to alterations in glutamatergic signaling, there is
ample evidence showing other neurotransmitter systems, such as
the cholinergic and dopaminergic, play a vital role in modulating
the induction, duration, and magnitude of synaptic plastic-
ity (Otani, 2003; Drever et al., 2011). ACh acts on a vari-
ety of different pre- and post-synaptic receptors throughout
the brain resulting in profoundly different outcomes depend-
ing on receptor location and subunit composition (Alkondon
and Albuquerque, 2004). Thus far, most studies have impli-
cated the involvement of G-protein coupled muscarinic receptors
in mediating these synaptic changes; however, more recently
nAChRs have come under investigation to understand their part
in these processes. In this section, the role of nAChRs in the
modulation of neurotransmission and drug-induced plasticity
will be discussed for the brain loci that have been implicated
to be important for the development of nicotine and ethanol
addiction.
MIDBRAIN: REWARD PATHWAY
The mesolimbic dopaminergic system, encompassing DA neu-
rons originating from the ventral tegmental area (VTA) that
project to the nucleus accumbens (NAc) and PFC, has long
been recognized as an important pathway mediating behavioral
responses to natural rewards as well as drugs of abuse. Essentially,
all drugs of abuse enhance extracellular DA in the NAc (Di Chiara
and Imperato, 1988) and blocking dopaminergic transmission
will attenuate the reinforcing properties of the drug (Corrigall
et al., 1992). Furthermore, this DA signal provides convergent
information to the system regarding reward expectation and envi-
ronmental cues related to drug intake (Di Chiara, 1999; Berke
and Hyman, 2000). It is not surprising, therefore that drug-
induced neural adaptations have been discovered in this circuit
and presumably contribute to addiction.
Ventral tegmental area
The VTA is modulated by excitatory glutamatergic inputs aris-
ing from the PFC, bed nucleus of the stria terminalis, amygdala,
pontomesencephalic tegmental nuclei (Mao andMcGehee, 2010),
and by a large population of inhibitory GABAergic interneu-
rons (Johnson and North, 1992; Theile et al., 2008) and afferents
that arise from heterogeneous sources (Geisler and Zahm, 2005).
There are several different nAChR subunits expressed in the VTA,
some of which are the α3, α4, α5, α6, α7, β2, and β3 subtypes
(Azam et al., 2002; Perry et al., 2002; Yang et al., 2009). The α4
and β2mRNAs are expressed in nearly all DAergic andGABAergic
VTA neurons, while α7 mRNA is distributed in only 40% of these
neurons (Nashmi and Lester, 2006). The α7∗ nAChRs are most
densely localized on pre-synaptic glutamatergic, but not choliner-
gic, terminals in the VTA (see Figure 2) (Klink et al., 2001; Jones
and Wonnacott, 2004).
Both ethanol and nicotine stimulate dopamine release in
the accumbens by modulating the activity of VTA neurons via
nAChRs (Champtiaux et al., 2003). In the presence of physio-
logically relevant doses of nicotine (100–500 nM) (Nguyen et al.,
2003; Parker et al., 2004), nAChRs are briefly activated followed
by rapid desensitization, which entails a reversible inactivation of
response. Therefore, nicotine’s mechanism of action and down-
stream consequences are attributed to both receptor activation
and desensitization (Mansvelder et al., 2002). The propensity
of these receptors to desensitize depends largely on the sub-
unit composition of the nAChR assembly. α7 nAChRs have a
much lower affinity for nicotine compared to β2-containing
nAChRs and are less susceptible to desensitization in the pres-
ence of relevant smoking-related concentrations (Mansvelder
and McGehee, 2002; Quick and Lester, 2002; Wooltorton et al.,
2003).
The initial few minutes of nicotine exposure will enhance DA
release in the NAc by activating α4β2∗ nAChRs on dopamine neu-
ronal soma (Pidoplichko et al., 1997; Mansvelder and McGehee,
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FIGURE 2 | Schematic representation of nAChR subtypes and circuit
function in the mesolimbic dopaminergic system. (A) Pyramidal cells in
layer V of the PFC lack nAChRs but their activity is modulated by excitatory
and inhibitory neurons that do express them. There are two types of
GABAergic interneurons, fast spiking and non-fast spiking, with only the latter
bearing nAChRs (α7 and α4β2∗ ). Distinct populations of glutamatergic inputs
express either α7 or α4β2∗ nAChRs while DA terminals projecting from the
VTA contain α4β2∗ nAChRs. Cholinergic inputs into the PFC arise from the
nucleus basalis of Meynert (nBM). (B) In the NAc, nAChRs (α4β2∗ , α6β2∗ ,
and α6α4β2∗ ) expressed on DAergic terminals from the VTA mediate DA
release based on the neuronal activity firing rate. A small population of
tonically active cholinergic interneurons (∼2%) is synchronized with DA cell
firing. Glutamatergic inputs from the PFC endow α7 nAChRs. (C) The VTA
receives cholinergic innervation from the pedunculopontine (PPn) and
laterodorsal tegmental nuclei (LDTn). In addition to the nAChRs localized on
DA cell bodies, DAergic cell firing is modulated by α4β2∗ (and possibly α7)
nAChRs expressed on GABAergic interneurons and excitatory glutamatergic
afferents from the PFC and the PPn.
2000); however, β2∗-containing receptors rapidly desensitize.
Simultaneously, nicotine acts on α4β2∗ nAChRs located on
GABAergic neurons to induce a transient inhibition of DA activ-
ity. These nicotinic receptors will also subsequently desensitize
in the presence of nicotine with a net result being a reduction
in the inhibitory control of GABA on dopaminergic transmis-
sion (Mansvelder and McGehee, 2002). On the same time scale,
nicotine binds to α7 nAChRs present on glutamatergic termi-
nals in the VTA, whose activation increases glutamate release
onto NMDA-type glutamate receptors located on dopaminergic
cell bodies and increases the frequency of spontaneous excitatory
postsynaptic currents (sEPSCs) (Mansvelder andMcGehee, 2000;
Schilstrom et al., 2000; Marchi et al., 2002; Pidoplichko et al.,
2004). Hence, the cumulative result of nicotine acting on nAChRs
in the VTA is enhanced excitatory input onto DA neurons which
triggers reward-related high frequency burst firing resulting in
increased accumbalDA outflow (Corrigall et al., 1994; Nisell et al.,
1994; Schilstrom et al., 2000; Pidoplichko et al., 2004).
Several labs have investigated the specific subunit composi-
tions of the nAChRs that may be critical in the development
of nicotine dependence using cell-based heterologous expression
systems, transgenic mouse lines, and pharmacological manipu-
lations using nAChR ligands in animal behavior models (Tapper
et al., 2004; Steensland et al., 2007; Chatterjee and Bartlett, 2010;
Cahir et al., 2011). The α4β2∗ and α6β2∗ nAChR subtypes play an
essential role in mediating the rewarding effects of nicotine (Dani
and De Biasi, 2001; Nashmi et al., 2007), demonstrated by a lack
of nicotine-elicited DA release in β2 and α4 knockout mice and
a decrease in nicotine self-administration by mice lacking the α4,
α6, or β2 subunits compared to wild-types (Picciotto et al., 1998;
Marubio et al., 2003; Pons et al., 2008). By contrast, the role α7
nAChRs play in the reinforcing properties of nicotine is less clear.
Deletion of the α7 did not affect nicotine conditioned place pref-
erence (Walters et al., 2006) or self-administration (Pons et al.,
2008); however, high doses of the α7 nAChR antagonist methylly-
caconitine attenuated nicotine self-administration (Markou and
Paterson, 2001) and reduced the rewarding effects of nicotine
when infused directly into the VTA (Laviolette and van der Kooy,
2003).
The effects of ethanol in the VTA are more complex than the
effects of nicotine. Ethanol, unlike nicotine, is not a direct ago-
nist at nAChRs (Cardoso et al., 1999; Zuo et al., 2002) but can
modulate DA release by influencing the function of nAChRs in
both the VTA and NAc (Ericson et al., 1998, 2003; Larsson et al.,
2005). While local perfusion of ethanol into the VTA does not
increase DA release in the accumbens, infusion of ethanol into
the accumbens does elevate extracellular DA to a similar degree
as systemic administration (Ericson et al., 2003; Tuomainen et al.,
2003). However, ethanol infused into both regions simultane-
ously resulted in higher DA levels than when injected into the
NAc alone (Lof et al., 2007). Furthermore, perfusion of mecamy-
lamine (MEC, non-selective nAChR antagonist) into the VTA,
but not into the NAc, blocks DA release stimulated by systemic
administration of ethanol. It has been postulated that ethanol’s
actions in the NAc may facilitate the release of endogenous ACh
in the VTA, leading to activation of nAChRs and consequently
elevating accumbal DA release (Larsson et al., 2005). In sup-
port, voluntary ethanol intake in rats has been shown to cause
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a significant increase in ACh levels in the VTA which is time-
locked with the DA increase in the NAc (Larsson et al., 2005).
It should be mentioned here that in addition to nAChRs, ethanol
is known to modulate DA neurotransmission through actions at
other molecular targets [for review (Vengeliene et al., 2008)]. For
example, ethanol (10–80mM) acting on pre-synaptic D1 recep-
tors can increase excitatory glutamate transmission in the VTA
and enhance DA release (Xiao et al., 2009).
While, it is relatively clear that α4β2∗ and α7 nAChRs play a
major role for nicotine mediated dopamine effects in the VTA, it
has beenmore difficult to determine the specific nAChR composi-
tions important for ethanol. Several subunit-specific antagonists
have been administered to mice both systemically and by direct
infusion into the brain. Ethanol-induced DA release in the NAc
and locomotor activity were blocked by systemic injections of
MEC but not by methyllycaconitine citrate (MLA, α7 antag-
onist) or dihydro-β-erythroidine (DHβE, broad-spectrum β2∗-
antagonist), suggesting ethanol’s stimulatory effects may not be
mediated by β2∗-containing or α7 nAChRs (Larsson et al., 2002).
Another study further defined which subunits were involved in
ethanol’s effects on the DAergic system by administering various
α-conotoxins into the VTA andmeasuring DA outflow in the NAc
following an ethanol challenge. Results showed that α-conotoxin
MII, selective for α3β2∗ and/or β3∗ and/or α6∗ subunits, signifi-
cantly reduced ethanol-stimulated DA release in the NAc, while
the selective α6∗ antagonist, α-conotoxin PIA-analog, showed
no effect (Larsson and Engel, 2004; Jerlhag et al., 2006). Taken
together, this evidence suggests ethanol’s actions in the VTA are
mediated by α3β2∗ and/or β3∗, rather than α4β2∗, α7, or α6∗
nAChRs; however, it remains unclear if these effects are due to
direct or indirect interactions of ethanol with nAChRs.
nAChR-mediated synaptic plasticity. In addition to augment-
ing transmitter release, drugs of abuse can induce long-lasting
plasticity within midbrain DA centers following both acute and
chronic drug administration (Gao et al., 2010). In the VTA,
drug-evoked NMDA-mediated plasticity may occur in a similar
fashion to that seen in the hippocampus and requires activation
of pre-synaptic voltage-gated ion channels. Indeed, several drugs
of abuse can elicit LTP in VTA excitatory synapses and increase
AMPA receptors without changing the number or function of
NMDA receptors (Saal et al., 2003; Jin et al., 2011). Activation
of nAChRs by nicotine likely influence the persistent potentiation
of these excitatory synapses (Jin et al., 2011), however at this time
it is unclear if and how nAChRs play a role in ethanol-mediated
NMDAR-dependent plasticity.
There is experimental evidence illustrating nicotine-induced
plasticity (Table 1) in VTA slice preparations where application
of nicotine (500 nM) was shown to increase the AMPA/NMDA
receptor ratio by increasing pre-synaptic release of glutamate.
This effect is mediated by α7 nAChRs since pre-incubation with
the α7 antagonist (MLA), but not the β2∗-antagonist (DHβE),
abolished the nicotine-induced LTP. In support, α7 knockout
mice lack this response to nicotine (Jin et al., 2011). Furthermore,
the nicotine-induced enhancement of excitatory currents lasts
after prolonged exposure suggesting a lack of α7 desensitiza-
tion (Pidoplichko et al., 2004) and persists even after nicotine is
removed from the bath, thereby indicating LTP (Mansvelder and
McGehee, 2000; Dani, 2001; Mansvelder et al., 2002).
Striatum
The striatum is a heterogeneous structure, with distinct anatom-
ical and functional subterritories that can be broadly classified
into the dorsal and ventral striatum. The majority (>90%) of the
neurons in the striatum are GABAergic medium spiny neurons
(MSN) with most (∼80%) of the synapses being asymmetric glu-
tamatergic inputs (Wilson, 2007; Tepper et al., 2008). In addition,
there are at least three other types of interneurons, including a
small population of cholinergic interneurons (∼2%) that pro-
vide a rather extensive arborization in this region to modulate
DA release probability (Zhou et al., 2002; Pakhotin and Bracci,
2007). The dopaminergic neurons arising from the VTA project
to the ventral striatum (NAc and part of the olfactory tubercle),
while the dorsal striatum (caudate-putamen) receives dopamin-
ergic inputs primarily from the substantia niagra pars compacta.
The ventral striatum is highly involved in the reinforcing effects
of drugs of abuse and receives extensive excitatory afferents from
the PFC, amygdala and hippocampus (Carelli, 2002; Volkow et al.,
2006). On the other hand, efferent projections from the motor
cortex to the dorsal striatum allows this subregion to gate senso-
rimotor function and have been implicated in the advanced stages
of habitual drug seeking (Fasano and Brambilla, 2002; Gerdeman
et al., 2003; Philibin et al., 2011).
There is a limited number of subunits (α4, α5, α6, β2, and β3)
densely localized on pre-synaptic DAergic axon terminals in the
striatum (Grady et al., 2007), where β2-containing nAChRs can
directly influence local DA release based on the neuronal activ-
ity firing rate (see Figure 2) (Zoli et al., 2002; Rice and Cragg,
2004). In the proposed model, ACh released from tonically active
striatal cholinergic interneurons normally acts on these receptors
to gate the probability of DA release and enhance the contrast
between tonic and phasic firing patterns. In a manner similar to
those in the VTA, these β2-nAChRs will rapidly desensitize fol-
lowing agonist application. Initial nicotine administration causes
a reduction of dopamine release from tonically active neurons;
however, a reward-related burst of action potentials will result in
even greater transmitter release due to loss of the normal mod-
ulatory control of endogenous Ach (Zhou et al., 2001; Rice and
Cragg, 2004; Salminen et al., 2004; Zhang and Sulzer, 2004).
Besides anatomical and connectivity differences, there are clear
distinctions in DA signaling between the ventral and dorsal stria-
tum which govern their specific brain functions and behavioral
output. For example, initial drug use will favor DA release in
the NAc shell rather than the dorsolateral striatum (Pontieri
et al., 1996; Di Chiara, 2002). Furthermore, these two regions
respond differently to stimulus trains that mimic action poten-
tials, with tonic and phasic firing eliciting greater DA release from
the dorsolateral striatum and NAc shell, respectively (Zhang et al.,
2009). Recently, it was demonstrated that activity-dependent DA
transmission in the ventral striatum is mainly controlled by α6∗-
containing nAChRs (α6α4β2β3 and α6β2∗) but in the dorsal
striatum non-α6 nAChRs (α4β2 and α4α5β2) are the key play-
ers (Exley et al., 2007, 2008, 2011). In summary, DA release in
the striatum is modulated by different nAChRs on pre-synaptic
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DAergic terminals in a frequency-dependent and region-specific
manner.
nAChR-mediated synaptic plasticity. In the NAc, synapses can
express both LTP and LTD (Kombian and Malenka, 1994)
but mainly NMDAR-dependent LTD has been demonstrated
following administration of psychostimulants, such as cocaine
and amphetamine, which involves the endocytosis of AMPARs.
Although in some situations ethanol has been shown to inhibit
NMDAR activity and associated plasticity (Blitzer et al., 1990),
activation of DA D1 receptors will diminish ethanol’s inhibition
of NMDARs thus promoting reinforcement and plasticity in the
NAc (Maldve et al., 2002). Ethanol treatment (50mM) has been
shown to cause a short-term depression of the striatal output
and this effect is sensitive to nAChR antagonists, MEC (10µM)
andMLA (40 nM), which block the depression of synaptic output
(Adermark et al., 2011).
Neuronal morphological changes, including increases in spine
density or dendritic length, have been reported following envi-
ronmental enrichment or drug administration (Johansson and
Belichenko, 2002; Leggio et al., 2005) and are thought to
reflect structural reorganization of neural circuits manifested by
molecular events discussed thus far in this review. In the NAc,
long-lasting structural plasticity has been demonstrated in MSN
following nicotine administration; however, these changes may
be dependent on treatment schedule and cohort age. One study
found an increase in dendritic length and spine density in the NAc
and PFC of adult rats after intermittent subcutaneous injections
of nicotine (Brown andKolb, 2001) while another reported signif-
icant increases in dendritic length and branch number in the NAc
shell of adolescent but not adult rats after continuous nicotine
administration (Table 1) (McDonald et al., 2007).
Prefrontal cortex
The PFC is a key brain region regulating executive cognitive func-
tion, attention, and working memory. Dysregulation of normal
signaling in the PFC, paralleled by deficits in cognitive perfor-
mance, have been observed in disorders such as Alzheimer’s
disease, schizophrenia, ADHD, and Parkinson’s disease (Picciotto
and Zoli, 2002). Interestingly, nicotine has been shown to enhance
cognition and attention in people suffering from these disorders
(Rezvani and Levin, 2001). The PFC has extensive connections to
reward and memory hubs, receiving DA innervations from the
VTA and providing glutamatergic efferents to the VTA and NAc
(Sesack et al., 1989; Carr and Sesack, 2000). It is now well estab-
lished that drugs of abuse may take over the normal operations of
this system, driving impulsivity and compulsive behaviors charac-
teristic of addiction (Lasseter et al., 2010). Recent neuroimaging
studies of PFC activity in drug-addicted subjects point to global
dysfunction in this region that is associated with a greater inci-
dence of relapse and heavier drug use (Goldstein and Volkow,
2011).
Similar to other brain regions, both α7 and non-α7 nAChR
signaling pathways converge in the PFC to modulate both excita-
tory and inhibitory neurotransmission (see Figure 2). Although
glutamatergic pyramidal cells in layer V lack nAChRs, nicotine
increases EPSCs and Glutamate release from thalamo-cortical
afferents that do express them (Gioanni et al., 1999; Lambe
et al., 2003; Couey et al., 2007). There are two populations of
GABAergic interneurons, fast spiking and non-fast spiking, with
only the latter bearing nAChRs (α7 and α4β2∗) (Gabbott et al.,
1997; Kawaguchi and Kondo, 2002). Activation of both α7 and
β2-containing nAChRs on glutamatergic nerve endings enhance
the release of excitatory amino acids but do so by different mech-
anisms (Dickinson et al., 2008). α7 nAChRs, predominately found
on ryanodine positive terminals, mediate release by calcium-
induced calcium release (CICR) which is coupled to the activation
of pre-synaptic extracellular signal-regulated kinase (ERK2) and
phosphorylation of synapsin-1. Non-α7 nAChRs recruit voltage-
gated calcium channels to induce release of [3H] D-aspartate
(Dickinson et al., 2008). Additionally, β2-containing nAChRs
govern glutamatergic neurotransmission and activation of this
receptor subtype by nicotine enhances glutamate release onto
layer 5 and 6 pyramidal neurons (Gioanni et al., 1999; Lambe
et al., 2003).
nAChR-mediated synaptic plasticity. DA has been shown to be
a strong modulator of synaptic plasticity in the PFC by fine tuning
glutamatergic transmission and facilitating the induction of LTP
or LTD (Otani et al., 2003; Matsuda et al., 2006). Systemic and
local administration of nicotine will enhance DA overflow in the
medial PFC of rodents (Nisell et al., 1996; Marshall et al., 1997)
and both β2-containing and α7 nAChRs influence this response
(Table 1) (Livingstone et al., 2009). In rat PFC slices, DA acting
through D1 and D2 receptors consistently resulted in LTD and
required postsynaptic depolarization and Ca2+ influx, but was
independent of NMDAR activation (Law-Tho et al., 1995; Otani
et al., 1998). In contrast, in vivo stimulation of the VTA (250Hz)
induced LTP in hippocampo-PFC projections through cooper-
ative actions of D1 and NMDA receptors (Gurden et al., 1999,
2000).
In the PFC, the relative timing of action potentials in pre- and
post-synaptic neurons is critically important for determining the
direction of synaptic plasticity, either LTP or LTD, and is referred
to as spike-timing-dependent plasticity (STDP) (Markram et al.,
1997; Bi and Poo, 1998; Couey et al., 2007). When the pre-
synaptic spike occurs before the post-synaptic spike in a time-
sensitive manner, robust LTP is induced; in contrast, reversing
the order of stimulation will result in LTD. Nicotine will increase
the threshold for induction of STDP under the same stimulus
conditions by reducing dendritic calcium signals that normally
occur with action potential propagation. Pyramidal neurons in
the PFC lack nAChRs but GABAergic inhibitory control of these
cells is modulated by nicotinic receptors (Couey et al., 2007). The
ability of nicotine to eliminate the induction of LTP is attributed
to activation of nAChRs on GABA interneurons and glutamater-
gic cells, which both ultimately increase the excitation of GABA
interneurons and enhance inhibition of layer V pyramidal neu-
rons. Application of a GABAA receptor antagonist or increasing
dendritic calcium signals with burst-like, post-synaptic stimula-
tion blocked nicotine’s effects and produced STDP similar to that
of control conditions. The authors speculate that one way nico-
tine may improve cognition is by increasing the signal-to-noise
ratio during PFC neural processing (Couey et al., 2007).
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Table 1 | nAChRs modulate synaptic transmission in the mesolimbic system.
Location nAChR subtype Agonist Outcome Mechanism References
Ventral tegmental area α7 on presynaptic
glutamatergic
neurons
Nicotine 1. ↑ Dopamine (DA) release
in the nucleus accumbens
2. Promotes long-term
potentiation (LTP)
1. ↑ glutamate release onto
NMDARs located on
DAergic cell bodies
2. ↑ frequency of
spontaneous postsynaptic
currents (sEPSCs)
Mansvelder and McGehee,
2000; Schilstrom et al.,
2000; Pidoplichko et al.,
2004
Nucleus accumbens Nicotine ↑ dendritic length and
branches
Brown and Kolb, 2001;
McDonald et al., 2007
Prefrontal cortex Activation of nAChRs
on soma of
GABAergic
interneurons
Nicotine ↑ threshold for induction of
spike-timing-dependent
plasticity
1. ↑ GABAergic inputs to
PFC layer 5 pyramidal
neurons
2. ↑ inhibitory postsynaptic
currents (IPSCs)
3. Reduces post-synaptic
Ca2+ signals
Couey et al., 2007
Activation of nAChRs
on glutamatergic
terminals
Nicotine ↑ threshold for induction of
spike-timing-dependent
plasticity
1. ↑ glutamate release onto
fast spiking interneurons
2. ↑ GABAergic inputs to
PFC layer 5 pyramidal
neurons
3. ↑ IPSCs
4. Reduces post-synaptic
Ca2+ signals
Couey et al., 2007
Nicotine ↑ dendritic length and
branches
Brown and Kolb, 2001
AMYGDALA AND HIPPOCAMPAL COMPLEX: LEARNING AND MEMORY
Nicotinic receptors have long been known to play a signifi-
cant role in cognition and disruption of normal nAChR func-
tion has been demonstrated in diseases such as Alzheimer’s and
schizophrenia (Paterson and Nordberg, 2000). nAChR agonists,
including nicotine, enhance cognition, memory and promote
learning by actions in a number of different brain circuits; how-
ever, the underlying mechanisms are still not completely under-
stood (Levin et al., 1994; Socci et al., 1995; Levin and Simon,
1998). An important aspect of addiction is the development of
context-drug associations and the formation of memories that
link drug-predictive cues to the reinforcing properties of the sub-
stance. Studies in both animals and humans have highlighted the
importance of associated learning of drug intake with both envi-
ronmental and internal cues in mediating future drug-seeking
and relapse (Fuchs et al., 2008).
The hippocampus and amygdala have been implicated in
mediating some of the cognitive-enhancing effects of nicotine,
supported by findings that show microinfusion of nAChR ago-
nists can enhance memory-related functions, while antagonists
impair them (Ohno et al., 1993; Felix and Levin, 1997). For exam-
ple, direct infusion of nicotine into basolateral nucleus of the
amygdala enhanced working memory and facilitated the acqui-
sition and consolidation of short- and long-term memories; on
the other hand, infusion of MLA had opposite effects on mem-
ory performance (Barros et al., 2005). Microinfusion of DHβE
or MLA into basolateral nucleus of rats resulted in working
memory deficits in the radial-arm maze, indicating both α7 and
α4β2∗ nAChRs in this area are involved in normal memory func-
tion (Addy et al., 2003). In addition, nicotine dose-dependently
stimulates the release of norepinephrine in the amygdala and hip-
pocampus by activating nAChRs localized on norepinephrinergic
neurons in the brainstem (Fu et al., 1998). Norepinephrine con-
tributes to memory function and the stress response (Liang et al.,
1990; Bremner et al., 1996), offering yet another mechanism by
which nicotine modulates these processes.
Few studies have reported the effects of ethanol on nAChRs in
these areas. One study reported that co-administration of ethanol
(i.p.) and nicotine infusions into the CA1 region or basolateral
nucleus of the amygdala produced a significant conditioned place
preference, while either drug alone did not; furthermore, this
response was blocked by microinjection of mecamylamine into
the CA1 or basolateral nucleus of the amygdala (Zarrindast et al.,
2010). Taken together, nAChRs in the amygdala and hippocam-
pus play a prominent role in not only learning and memory but
also reward-related learning.
Hippocampus
From an anatomical prospective, the hippocampus is inte-
grally linked to brain circuits involved in addiction, receiving
direct dopaminergic input from midbrain neurons and pro-
viding extensive efferent connections to the ventral striatum,
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FIGURE 3 | Schematic representation of nAChR subtypes and
circuit function in the hippocampus and amygdala. (A) In the
hippocampus, α7 and α4β2∗ nAChRs are abundantly expressed on pyramidal
cells and inhibitory interneurons. GABAergic interneurons have pre-synaptic
α7 nAChRs and somato-dendritic expression of α7 and α4β2∗ nAChRs.
Glutamatergic afferents have predominately pre-synaptic α7 nAChRs and only
low levels of α3β4∗ . (B) In the amygdala, cholinergic inputs from the
basal forebrain synapse in proximity to pre-synaptic nAChRs that
modulate both excitatory and inhibitory synaptic transmission.
Glutamatergic afferents and pyramidal neurons endow α7 nAChRs
and GABAergic interneurons express multiple nAChRs (α7, α4β2∗ , and
α3β4∗ ).
amygdala, and PFC (Kelley, 2004). Therefore, alterations in
structure or function in the hippocampus may be translated
by other brain regions that drive maladaptive behaviors associ-
ated with addiction. Most studies investigating the involvement
of nAChRs in synaptic plasticity have been conducted in the
hippocampus.
The α7 and α4β2∗ nAChRs (see Figure 3) are abundantly
expressed on GABAergic interneurons and pyramidal cells within
the hippocampus and are capable of modulating intracellu-
lar signaling molecules and downstream effectors that gov-
ern plasticity (Jones and Yakel, 1997; Vizi and Lendvai, 1999).
GABAergic interneuron populations express α7 nAChRs on
pre-synaptic terminals, whereas somato-dendritic compartments
endow both α7 and α4β2∗ nicotinic receptors (Radcliffe et al.,
1999; Alkondon and Albuquerque, 2001). Furthermore, mod-
ulation of glutamate synaptic transmission to pyramidal neu-
rons in the CA1 region is attributed to predominately α7
nAChRs but also to a minimal number of α3β4∗ nAChRs
(Gray et al., 1996; Ji et al., 2001; Alkondon and Albuquerque,
2002).
nAChR-mediated synaptic plasticity. Nicotinic receptors exert
a temporally- and spatially-dependent bidirectional control over
synaptic plasticity, both in vitro and in vivo (Table 2). For exam-
ple, in the CA1 region of hippocampal slices ACh and nico-
tine can act on post-synaptic receptors of pyramidal neurons
to increase intracellular Ca2+ which facilitates the conversion of
short-term potentiation to LTP by reducing the threshold needed
for induction (Fujii et al., 1999; Ji and Dani, 2000; Nakauchi
et al., 2007) or by attenuating the inhibitory input of interneu-
rons to pyramidal cells (Ji and Dani, 2000; Yamazaki et al.,
2005); these effects are mediated by both the activation of non-α7
nAChRs and the inactivation of α7 nAChRs (Fujii et al., 2000a).
Furthermore, blunting the evoked release of inhibitory GABA
onto pyramidal cells to facilitate nicotine-induced LTP induction
was shown to rely on desensitization of non-α7 nAChRs (Fujii
et al., 2000b; Yamazaki et al., 2005; Nakauchi et al., 2007).
Additionally, activation of nAChRs on hippocampal interneu-
rons can induce LTP or LTD depending on the exact timing
of agonist application in respect to the pre-synaptic stimula-
tion (Ji et al., 2001; Ge and Dani, 2005). Furthermore, acti-
vation of α7 nAChRs on pre-synaptic glutamatergic terminals
can increase the frequency of miniature EPSCs and enhance
glutamate release onto pyramidal neurons offering yet another
mechanism for the modulation of plasticity (Gray et al., 1996;
Radcliffe and Dani, 1998). In the CA3 region of hippocam-
pal slices, bath application of nicotine can drive the pyrami-
dal cells above threshold in the absence of an action poten-
tial by activating pre-synaptic nAChRs located on glutamater-
gic terminals. Activation of these receptors enhances miniature
EPSCs and glutamate release through mobilization of intra-
cellular calcium stores by CICR (Sharma and Vijayaraghavan,
2003).
Within the dentate gyrus, induction of LTP by nicotine
required activation of mGLuR5 and L-type Ca2+ channels, as
well as Ca2+ release from ryanodine-sensitive stores and was α7
nAChR-dependent (Welsby et al., 2006, 2009). in vivo studies
in mice showed nicotine or epibatidine, an α4β2 nAChR ago-
nist, dose-dependently induced synaptic plasticity in the dentate
gyrus and importantly, required intact midbrain DA signaling
(Matsuyama et al., 2000; Matsuyama and Matsumoto, 2003; Tang
and Dani, 2009). In the developing brain, long-lasting changes
in synaptic transmission were observed following a single expo-
sure to nicotine in the hippocampus. nAChR signaling facilitated
the conversion of pre-synaptic silent synapses into functional
ones and was shown to be dependent on α7 nAChRs most likely
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localized on pre-synaptic glutamatergic nerve endings (Maggi
et al., 2003). Together these findings strongly imply that the tim-
ing and location of nAChR activity are important determinants
for synaptic plasticity in the hippocampus.
Amygdala
The amygdala is another essential brain region implicated in
memory processing, particularly for encoding the emotional and
motivational significance of environmental stimuli as well as ini-
tiating innate unconditioned responses to aversive situations. It is
a central region for integrating sensory and cognitive information
through its extensive connections to other limbic structures, the
cortex, hippocampus, and thalamus (LeDoux, 1996). In addition,
experimental evidence strongly suggests drugs of abuse act on this
system and can modify synaptic events, especially during periods
of withdrawal (McCool et al., 2010).
Reciprocal connections between the amygdala, hypothala-
mus and parabrachial nucleus are known to regulate the
hypothalamic-pituitary-adrenal axis and autonomic responses to
conditioned fear (Takeuchi et al., 1982; Gray et al., 1989). The
amygdala also participates in stress- and reward-related behav-
iors through its connections to the PFC and NAc, respectively
(Simpson et al., 2001; Myers-Schulz and Koenigs, 2012; Stuber
et al., 2011). The basolateral nucleus of the amygdala is densely
innervated by cholinergic projections arising from the basal fore-
brain (Sah et al., 2003), with cholinergic inputs synapsing on
pyramidal neurons (89% of efferents) and GABAergic interneu-
rons (Muller et al., 2011). Different pathways reside within the
amygdala and are responsible for various functions regarding the
acquisition, expression, and retrieval of fear memories as well as
unconditioned behaviors (LeDoux, 2003).
Functional nAChRs expressed on pyramidal cells (somato-
dendritic α7), GABAergic interneurons (α7, α4β2∗, and α3β4∗),
and glutamatergic afferents (α7) modulate synaptic transmission
in the amygdala (see Figure 3) (Hill et al., 1993; Perry et al.,
2002; Klein and Yakel, 2006). Whole cell patch-clamp recordings
demonstrated nicotine increases the frequency of both gluta-
matergic and GABAergic spontaneous post synaptic currents
(PSCs) and this effect was sensitive to the α7-selective antago-
nist α-bungarotoxin, thus implicating a role of pre-synaptic α7
nAChRs (Barazangi and Role, 2001). Another report showed
that activation of predominately α3β4∗ nAChRs on GABAergic
interneurons in the basolateral nucleus of the amygdala were
responsible for the enhanced frequency of inhibitory PSCs (Zhu
et al., 2005).
nAChR-mediated synaptic plasticity. In the amygdala (Table 2),
nicotine has been shown to facilitate LTP in a pathway-specific
manner. Robust LTP in amygdala slices from mice that received
nicotine treatment for 7 days compared to controls and per-
sisted 72 h after nicotine cessation. Even just one day of nicotine
exposure significantly enhanced LTP. The nicotine-induced facil-
itation of LTP was found to be dependent on both α7 and β2-
containing nAChRs and at least partially, to activation of nAChRs
on GABAergic interneurons that ultimately reduce inhibition of
pyramidal neurons. Furthermore, LTP was completely blocked
by D-APV, an NMDAR antagonist, demonstrating the essential
role of NMDARs in nicotine-mediated plasticity in the amygdala.
The authors suggest that as seen in other brain regions, nico-
tine may also be acting on pre-synaptic nAChRs on glutamatergic
terminals to enhance glutamate release or increasing postsy-
naptic Ca2+ influx through voltage-dependent calcium channels
(Huang et al., 2008). At this time, little is known about nicotinic
receptor-mediated plasticity in the amygdala. Ethanol is capable
of modulating synaptic changes in this circuit but it has yet to be
elucidated if and how nicotinic receptors are involved.
CHANGES IN nAChRs NUMBER AND FUNCTION
NICOTINE
A primary mechanism underlying long-lasting synaptic plas-
ticity is a change in the number or expression of membrane-
bound receptors. Long-term exposure to nicotine induces an
up-regulation of specific subtypes of nAChRs and increases the
number of high-affinity nicotinic binding sites across multiple
brain regions in the brains of postmortem human smokers (Perry
et al., 1999) and nicotine-treated rodents (Schwartz and Kellar,
1983; Flores et al., 1992; Marks et al., 1992; Gentry and Lukas,
2002). The concept of up-regulation of nAChRs is somewhat
unexpected and contradictory to what the homeostatic model
would predict. Following chronic drug use, receptors are usually
down regulated in response to excessive stimulation as an adap-
tive mechanism to adjust the neural network to a pre-exposure
point. Evidence suggests that nicotine causes a rapid desensitiza-
tion of nAChRs, and this loss in receptor function would promote
up-regulation to compensate for the diminished signaling of inac-
tivated receptors over prolonged periods of time (Fenster et al.,
1999a,b). These changes result in higher sensitivity to nicotine
and have been correlated with nicotine addiction [see review,
Govind et al. (2009)].
Several mechanisms have been proposed for nicotine-induced
up-regulation of nAChRs and it is quite likely that more than one
mechanism is responsible for this phenomenon. There is con-
troversy surrounding how this up-regulation of surface receptors
occurs but it does not appear to be due to a change in sub-
unit mRNA transcript levels (Marks et al., 1992; Bencherif et al.,
1995; Ke et al., 1998) but has been proposed to be caused by
increased translation or alterations in receptor assembly (Wang
et al., 1998; Nashmi et al., 2003), trafficking (Harkness and
Millar, 2002), and/or decreased receptor turnover (Wang et al.,
1998). For example, nicotine has been shown to inhibit the
turnover of cell-surface receptors of the α4β2∗ conformation.
The authors, using cell line M10, demonstate that up-regulation
of α4β2∗ nAChRs is due to an intrinsic property of these pro-
teins and results from a conformational change of the receptors
that makes their degradation and removal from the cell surface
slower (Peng et al., 1994). Another possible mechanism is an
increase in receptor trafficking to the cell surface upon long expo-
sures to nicotine (Harkness and Millar, 2002). An increase in the
intracellular receptor pool caused by enhanced receptor assembly
and/or maturation of the subunits in the endoplasmic reticu-
lum has also been proposed (Nashmi et al., 2003). Additionally,
nicotine can reportedly facilitate receptor maturation by acting
as a chaperone in the endoplasmic reticulum (Nashmi et al.,
2003; Srinivasan et al., 2011). However, membrane-impermanent
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Table 2 | nAChRs modulate synaptic plasticity in the hippocampus and amygdala.
Location nAChR subtypes Agonist Outcome Mechanism References
Hippocampus CA1 region Post-synaptic activation
of non-α7 and
inactivation of α7
Nicotine
(acute/chronic)
and ACh
1. Reduces threshold
for long-term
potentiation (LTP)
2. Converts
short-term
potentiation to LTP
1. ↑ intracellular Ca2+ in
pyramidal neurons
2. ↑ neuronal excitability
Fujii et al., 1999,
2000a; Ji and Dani,
2000; Nakauchi et al.,
2007
Desensitization of
non-α7 on pre-synaptic
GABAergic interneurons
Nicotine Promotes LTP
induction
Disinhibition of pyramidal
neurons
Ji and Dani, 2000;
Fujii et al., 2000b;
Yamazaki et al., 2005
Activation α7 on
glutamatergic nerve
terminals
Nicotine and ACh Silent synapses to
functional
Facilitation of synaptic
transmission
Maggi et al., 2003
α7 on presynaptic
glutamatergic neurons
Nicotine Promotes LTP
induction
1. Ca2+ influx—excitatory
post-synaptic currents
(EPSCs)
2. ↑ glutamate release
onto pyramidal neurons
Gray et al., 1996;
Radcliffe and Dani,
1998
Dependent on type and
location of nAChRs
ACh LTP or LTD induction Timing of postsynaptic
nAChR activation and
pre-synaptic stimulation
Ji et al., 2001; Maggi
et al., 2004; Ge and
Dani, 2005
Hippocampus CA3 region nAChRs activation on
glutamatergic neurons
Nicotine Brings post-synaptic
pyramidal neurons to
action potential
threshold
1. Ca2+ influx-EPSCs
2. Ca2+ induced Ca2+
release
3. ↑ glutamate release
onto pyramidal neurons
Sharma and
Vijayaraghavan, 2003
Dentate gyrus α7 Nicotine Enhance
tetanus-induced LTP
1. Depedent on NMDAR
and voltage-activated
Ca2+channels
2. ryanodine-sensitive
Ca2+ stores
3. Ca2+ induced Ca2+
release
Welsby et al., 2006,
2009
α7 and α4β2* Nicotine,
epibatidine,
choline
LTP induction Requires dopamine input Matsuyama et al.,
2000; Matsuyama
and Matsumoto,
2003; Tang and Dani,
2009
Amygdala α7 and β2-containing Nicotine (in vivo
exposure)
Facilitate LTP 1. NMDAR-dependent
2. Reduces inhibition of
pyramidal neurons
Huang et al., 2008
ligands can also induce up-regulation of surface receptors; there-
fore, second messengers must exist that are sufficient to drive
this response (Whiteaker et al., 1998; Darsow et al., 2005).
In order for nicotine-induced up-regulation to occur, nAChRs
must pass through the secretory pathway before being inserted
into the membrane (Darsow et al., 2005) suggesting that up-
regulation is not due to stabilization of nAChRs in the plasma
membrane.
The up-regulation of nAChRs varies with subunit compo-
sition, cell type and brain region. Amongst the different sub-
types of nAChRs, studies have shown the α4β2∗, α3β2∗, and
α6β2∗ nAChRs can be activated, desensitized and up-regulated
by nicotine concentrations (peak levels between 100 and 500 nM)
achieved following cigarette smoking in humans (Nguyen et al.,
2003; Parker et al., 2004). The α7 and β4-containing nAChRs
appear to be less sensitive to nicotine and require higher con-
centrations (<10µM) to activate them. The two accessory
subunits α5 and β3 appear to inhibit nicotine-induced recep-
tor up-regulation or down-regulation. In this respect, no up-
regulation was reported when α5 subunits were associated with
α4β2 nAChRs (Mao et al., 2008) and in the striatum, α6-
containing receptors without β3 were down-regulated by nico-
tine while those containing β3 were unaffected (Perry et al.,
2007).
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ETHANOL
There are a limited number of studies that have investigated
ethanol-induced changes in expression of nAChRs and therefore
it is certainly an area of research which should be expounded
upon. In vitro experiments demonstrated nAChRs are directly
affected by ethanol and after long-term exposure these recep-
tors may undergo anatomical and functional changes, possibly
by altering receptor expression or composition (Dohrman and
Reiter, 2003). In M10 cells, ethanol modulates the number of
nAChRs by initially blunting the expression during short expo-
sure (6–72 h) but increasing it with longer incubation periods
(96 h). Similar results were found with co-application of relatively
high concentrations of nicotine (1µM) and ethanol (100mM);
moreover, the elevated receptor expression after chronic expo-
sure (96 h) remained up to 7 days following the removal of the
drugs (Dohrman and Reiter, 2003). In a different study, long-
term consumption of ethanol (5 months) by rats increased the
levels of [3H]-nicotinic binding in the hypothalamus and tha-
lamus, and decreased the levels in the hippocampus (Yoshida
et al., 1982). In ethanol-treated (6 months) mice, small changes
in [3H]-nicotinic binding were found only in the thalamus and
in just one of the mice strains tested, leading the authors to con-
clude this effect is brain region specific and genetic factors may
influence this response (Booker and Collins, 1997). These effects
were not seen in mouse brains following short-term (1–2 weeks)
ethanol treatment (Burch et al., 1988; de Fiebre and Collins,
1993).
Finally, receptor up-regulation should enhance neuronal
excitability and favor induction of drug-induced LTP. Thus, it
can be hypothesized that drug exposure leads to a chain reaction
of interrelated events: up-regulation of nAChRs—LTP/LTD—
enhanced neurotransmitter release—behavioral modifications,
which will all contribute to uncontrollable drug use (Vezina,
2004).
BEHAVIORAL IMPLICATIONS OF PLASTICITY
One behavioral correlate of synaptic plasticity is the manifesta-
tion of locomotor sensitization, which is defined as an enhanced
locomotor response after repeated exposures to a drug compared
to the activity measured during the first drug administration.
Increased locomotor response to prolonged nicotine, ethanol,
cocaine, amphetamine, and methamphetamine has been exten-
sively studied in rodent animal models and is thought to have
relevance to drug seeking and relapse in humans (Steketee and
Kalivas, 2011).
Data suggests repeated administration of a drug causes altered
dopaminergic and glutamatergic transmission in the mesocorti-
colimbic system (Vanderschuren and Kalivas, 2000; Pascual et al.,
2009) and is associated with the neuroplastic changes discussed
thus far in this review. Up-regulation of receptors may not be
the sole cause of drug-induced locomotor sensitization, since the
timing of these events don’t necessarily correlate, but likely plays
a role in the development of this behavioral response (Vezina,
2007). nAChRs are up-regulated in the entire brain after long
exposures to nicotine but nAChRs in the VTA and NAc are the
most probable regions implicated for the induction of sensitiza-
tion (Parker et al., 2004). Long-lasting behavioral sensitization
has been shown to correlate well with LTP, reflecting persistent
adaptations in neural mechanisms such as the modulation of
synaptic strengths, change in neurotransmitter release, alterations
in gene expression and formation of new connections between
synapses. In the next section, we will focus on nicotine and
ethanol’s effect on behavioral sensitization.
NICOTINE AND ETHANOL STIMULATED LOCOMOTOR SENSITIZATION
Several studies have shown nicotine induces locomotor sensitiza-
tion in mice and rats by a range of nicotine doses (0.1–2mg/kg,
i.p) and by different schedules of administration (Domino, 2001;
Collins and Izenwasser, 2004; Saito et al., 2005). Typically, the
first nicotine injection produces locomotor depression which is
rapidly overcome by subsequent nicotine exposure and is associ-
ated with the development of tolerance to the drug’s acute depres-
sant effect (Morrison and Stephenson, 1972). This enhanced
locomotor activity in response to repeated nicotine administra-
tion is long-lasting (Miller et al., 2001) and central nicotinic
receptors play a key role. In support, mecamylamine (Bevins
and Besheer, 2001), lobeline (non-selective nAChR antagonists)
(Miller et al., 2003), and SSR591813 (α4β2 partial agonist)
(Cohen et al., 2003) all blocked induction of sensitization by nico-
tine. In a separate study, pre-treatment with mecamylamine but
not α-bungarotoxin (α7 nAChR antagonist) prevented sensitiza-
tion, implicating non-α7 nAChRs in mediating the locomotor-
stimulant effects of nicotine (Kempsill and Pratt, 2000).
While nicotine–induced sensitization has been widely stud-
ied, motor stimulant effects of ethanol have generally received
less attention. The development of sensitization to ethanol is
predominantly shown in mice. Similar to nicotine-induced loco-
motor activity, mice were pre-treated with ethanol injections
(1.5–2.5 g/kg, i.p) for 7–10 days. Following this exposure, they
were challenged with a single injection of ethanol after a period
of withdrawal (7–30 days). Results indicated the mice were sig-
nificantly more sensitive to the locomotor stimulating effects of
ethanol during this challenge session and this effect lasted up to
29 days following termination of ethanol administration (Lessov
and Phillips, 1998; Itzhak and Martin, 2000; Fish et al., 2002).
Under similar circumstances, stimulation of locomotor activity
by ethanol consuming rats has also been reported (Hoshaw and
Lewis, 2001).
There is a substantial amount of evidence supporting the idea
that activation of the DAergic system is required for the emer-
gence of the sensitized locomotor response, with induction of
sensitization attributed to the VTA and the expression to the NAc
(Mao and McGehee, 2010). Through actions on nAChRs in this
system, both nicotine and ethanol influence neuronal activity fir-
ing rate (Mereu et al., 1987), bursting activity (Zhang and Sulzer,
2004), and corresponding neurotransmitter release—including
DA, GABA, and Glutamate, which are surely contributing to the
drugs’ locomotor-stimulating effects (Nestby et al., 1997; Guo
et al., 1998; Tzschentke, 2001; Lambe et al., 2003; Broadbent
et al., 2005; Meyer et al., 2008; Mao et al., 2011). For example,
intracranial injections of nicotine directly into the VTA results in
locomotor sensitization (Reavill and Stolerman, 1990; Kita et al.,
1992) and is associated with an increase in DA and c-Fos-like
immunoreactivity (an indicator of neuronal activation) in the
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NAc (Panagis et al., 1996; Shim et al., 2001). For these reasons,
behavioral sensitization induced by nicotine and ethanol can be
partially attributed to their actions on nAChRs in the midbrain
reward pathway.
CROSS SENSITIZATION
While repeated exposure to a single drug can produce behav-
ioral sensitization, sometimes cross-sensitization between drugs
is observed. In this type of experiment, animals are repetitively
treated with a particular drug for a period of time and then chal-
lenged with a different drug after a defined drug-free period.
Although the animal has experienced a different drug, locomotor
sensitivity to the challenge drug is observed, indicating a com-
mon molecular substrate. For example, caffeine, cocaine, and
amphetamine have all been shown to produce cross-sensitization
to nicotine-induced hyperlocomotion (Collins and Izenwasser,
2004; Celik et al., 2006; Santos et al., 2009). Others studies have
demonstrated cocaine and ethanol exhibit cross-sensitization of
locomotor effects (Itzhak and Martin, 1999). The findings for
nicotine and ethanol are mixed, with some studies reporting
no cross-sensitization (Watson and Little, 1999; Darbra et al.,
2004) while others report observing this phenomenon (Biala
and Weglinska, 2004; Biala and Budzynska, 2010). There are,
however, other behavioral measures that clearly illustrate a com-
mon molecular interaction between these two substances. In
this respect, rats with prior exposure to nicotine show increased
ethanol consumption (Blomqvist et al., 1996); furthermore,
ethanol-induced locomotor activity and accumbal DA release is
blocked by mecamylamine, indicating a pivotal role of nAChRs in
ethanol’s behavioral effects (Blomqvist et al., 1992; Larsson et al.,
2002). In addition, drugs acting through nAChRs, including a
partial agonist (varenicline) and non-selective antagonist (MEC),
reduce ethanol consumption in both rodents and humans (Le
et al., 2000; Steensland et al., 2007; McKee et al., 2009).
CONCLUSIONS
This review has summarized multiple different mechanisms that
underlie persistent, long-lasting changes in synaptic efficacy fol-
lowing administration of addictive drugs. It is becoming more
and more evident that nicotinic receptors significantly facil-
itate the induction and maintenance of plasticity—including
LTP, LTD, and structural changes—in the hippocampus, amyg-
dala, and mesolimbic dopaminergic system, thus contributing
to the molecular underpinnings of nicotine and alcohol addic-
tion. Nicotine exerts its powerful effects by a dynamic, parallel
activation, and desensitization of nAChRs. Up-regulation of
nAChRs following nicotine treatment reflects a compensatory
response to excessive receptor stimulation, and there is com-
pelling experimental evidence to suggest this plays a major part
in nicotine dependence. Although few studies have addressed
ethanol-induced synaptic plasticity via interactions with nico-
tinic receptors, ethanol undoubtedly potentiates nAChR currents
and drugs targeting nAChRs can attenuate voluntary alcohol con-
sumption in both rodents and humans. Importantly, there is
a need to understand the molecular and cellular ramifications
of co-administration of nicotine and ethanol due to the high
comorbidity of these substances in human addicts. Future studies
should aim to unravel the common neural mechanisms shared
by these two drugs. This review has touched upon the behav-
ioral outcomes of repeated administration of drugs of abuse,
thus suggesting that long-lasting changes in synaptic strength and
modification of neurotransmitter release contribute to locomo-
tor sensitization. Both nicotine and ethanol alone clearly induce
behavioral sensitization, and cross-sensitization may or may not
occur between these two substances. At this time, a large body
of literature exists regarding the mechanism of action of nico-
tine but there is still much to be elucidated pertaining to ethanol’s
actions at nAChRs for synaptic plasticity and behavioral sensiti-
zation.
Clearly, nicotine can enhance cognitive function and propa-
gate LTP and thereby these processes are likely, at least in part,
what underlie the highly addictive nature of this compound.
Reports from human users of cognitive deficits and strong cue-
induced cravings during nicotine withdrawal undoubtedly con-
tribute to the high incidence of relapse. Medications that target
neural substrates directly involved in both learning and addiction
may offer a novel pharmacotherapeutic approach for nicotine
dependence as well as other drugs of abuse. More intriguing yet is
the possibility that novel therapeutic avenues may be directed to
diminish drug-associated memories or facilitate the formation of
new memories with less maladaptive behavioral consequences.
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